Multiply drug-resistant human KB carcinoma cells have decreased amounts of a 75-kDa and a 72-kDa glycoprotein.

N Richert, SI Akiyama, DW Shen… - Proceedings of the …, 1985 - National Acad Sciences
N Richert, SI Akiyama, DW Shen, MM Gottesman, I Pastan
Proceedings of the National Academy of Sciences, 1985National Acad Sciences
Human KB carcinoma cells were selected in sequential steps for resistance to colchicine
and found to be cross-resistant to multiple drugs, including vinblastine, adriamycin, and
actinomycin D. Compared with the parental line, the multiply resistant cells have decreased
amounts of two [35S] methionine-labeled proteins with apparent molecular masses of 75
and 72 kDa. These proteins reappear in a revertant, drug-sensitive cell line. Both proteins
are labeled with [14C] glucosamine and are retained on a wheat germ agglutinin-agarose …
Human KB carcinoma cells were selected in sequential steps for resistance to colchicine and found to be cross-resistant to multiple drugs, including vinblastine, adriamycin, and actinomycin D. Compared with the parental line, the multiply resistant cells have decreased amounts of two [35S]methionine-labeled proteins with apparent molecular masses of 75 and 72 kDa. These proteins reappear in a revertant, drug-sensitive cell line. Both proteins are labeled with [14C]glucosamine and are retained on a wheat germ agglutinin-agarose column, indicating that they are glycoproteins. These data suggest that in this human cell line, these two glycoproteins can serve as a marker of the multiple drug-resistance phenotype and may play a role in its etiology.
National Acad Sciences